Erythropoietin Therapy for Subarachnoid Hemorrhage
NCT00140010
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
80
Enrollment
OTHER
Sponsor class
Conditions
Aneurysmal Subarachnoid Hemorrhage
Interventions
DRUG:
erythropoietin beta
Sponsor
University of Cambridge
Collaborators
[object Object]
[object Object]